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ABSTRACT
Our aim was to study the inhibitory and facilitatory factors
possibly accounting for the undetectable activity of the GnRH
pulse generator in late fetal life in vitro and its awakening in
early postnatal life. Gamma aminobutyric acid (GABAA) recep-
tor antagonism using SR 95 531 did not cause any secretory
pulse in fetal explants, whereas a significant stimulation of
GnRH pulse frequency was obtained at 5 and 15 days. GnRH
secretory response to repeated N-methyl-D-aspartate (NMDA)
stimulation showed progressive disappearance, indicating that
the inhibitory autofeedback was operating. GnRH release
caused by glutamine was respectively 9% and 20% of that
evoked by glutamate in fetal and 5-day-old rats whereas both
amino acids were equally active at 15 days. Explants obtained
after cesarean section performed at onset of labor did not show
any secretory pulse, while pulses could be observed with ex-
plants obtained 2 h after vaginal delivery. Incubation of fetal
explants with oxytocin (1028 M) or prostaglandin E2 (PGE2) (1026
M) resulted in occurrence of GnRH secretory pulses. A facili-
tatory effect of the oxytocin was shown to persist on Days 1, 5,
and 15 and inhibitory effects of an oxytocin receptor antagonist
provided some evidence of endogenous oxytocin involvement.
We conclude that, in the fetal rat hypothalamus, GnRH inhibi-
tory autofeedback and GABAergic inputs do not account for the
absence of pulsatile GnRH secretion in vitro. A low rate of glu-
tamate biosynthesis from glutamine is a possibly limiting factor.
Oxytocin and PGE2 can play a facilitatory role in the postpartal
occurrence of pulsatile GnRH secretion.
gonadotropin-releasing hormone, hypothalamus, neuroendocri-
nology, neurotransmitters, oxytocin
INTRODUCTION
The pituitary gonadotrophin secretion is determined by
the pulsatile secretion of GnRH, for which the existence of
a hypothalamic pulse generator has been proposed [1]. The
observation of episodic gonadotropin-releasing hormone
(GnRH) secretion from immortalized murine GnRH neu-
rons [2, 3] and the recent demonstration of pulsatile GnRH
release using cultured GnRH neurons from the primate and
rat embryonic olfactory placode [4, 5] pointed to the ex-
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istence of a pulse generator intrinsic to GnRH neurons. In
addition, in explants of the retrochiasmatic rat hypothala-
mus, where no immunocytochemically GnRH cell bodies
could be observed, the secretion of GnRH was typically
pulsatile in vitro, suggesting the existence of a pulse-gen-
erating network extrinsic to the GnRH neurons [6]. Pulsa-
tile GnRH secretion occurred from the first postnatal day
and progressively increased in frequency till the age of 25
days, before onset of puberty [7–9]. However, no pulsatile
GnRH secretion could be observed with fetal explants ob-
tained on Day 20–21 of gestation [7]. In the present work,
we further studied the facilitatory and inhibitory mecha-
nisms possibly accounting for the early postnatal occur-
rence of pulsatile GnRH secretion.
In previous studies from this laboratory, repeated stim-
ulation of fetal rat hypothalamic explants with N-methyl-
D-aspartate (NMDA) was shown to result in intermittent
GnRH secretory response [7]. It was therefore concluded
that fetal absence of pulsatility did not result from immature
synthesis of GnRH or absence of NMDA receptors. An
inhibitory autofeedback effect on GnRH secretion at the
NMDA receptors is mediated by the GnRH[1–5] subproduct
[10]. Such an autofeedback was found to operate already
in late fetal life, but prevention of this mechanism with
prolyl-endopeptidase antagonists did not cause any pulse to
occur at that time [7]. Here, we studied the possible con-
tribution of non-NMDA receptors during perinatal life.
Gamma aminobutyric acid (GABAA) receptors were
found to mediate a potent inhibition of the GnRH pulse
generator in the juvenile primate in vivo [11, 12] and in
the prepubertal rat hypothalamus in vitro [13]. Here, we
studied the possible earlier involvement of GABAergic in-
puts considering both a possible inhibitory role as just men-
tioned or a possible stimulatory effect of GABA that was
reported in the perinatal period and in some in vitro con-
ditions [14, 15]. We showed earlier that increased biosyn-
thesis of glutamate from glutamine through glutaminase
could contribute to an increase in frequency of pulsatile
GnRH secretion between 15 and 25 days [16]. That mech-
anism was also studied as a possible factor stimulating pul-
satile GnRH secretion earlier in life. Finally, because par-
turition took place right before pulsatile GnRH secretion
became obvious, the possible role of oxytocin and prosta-
glandin E2 (PGE2) was investigated.
MATERIALS AND METHODS
Animals
Male Wistar rats were housed in temperature and light-controlled con-
ditions with water and standard rat pellets ad libitum. The prepubertal pups
were with lactating mothers until weaning, which was at 3 wk of age. The
protocols were approved by the University Committee on Animal Re-
search. Fetal rats were used irrespective of gender. Postnatally, male rats
were used to be consistent with our previous conditions [7]. Fetal age was
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determined based on vaginal plug observed at daily examination after
mating. The day of birth was considered as Postnatal Day 1.
Hypothalamic Explant Incubation and GnRH RIA
After decapitation, the retrochiasmatic hypothalamus was rapidly dis-
sected and transferred into a static incubator as described previously [17,
18]. In each experiment, 12–15 explants were studied individually for 4–
6 h through collection and renewal of the incubation medium (0.5 ml)
every 7.5 min. The incubation medium was MEM (phenol red free min-
imum essential medium, Gibco, Invitrogen Corporation, Belgium) supple-
mented with glycine (10 nM), magnesium (1 mM), and glucose (25 mM).
The incubation medium was enriched with 20 mM of bacitracin, an inhib-
itor of GnRH degradation by endopeptidases. We showed previously that
pulsatile GnRH secretion was not affected by bacitracin in explants ob-
tained from fetuses and at 5 and 15 days postnatally [7]. No bacitracin
was used only when 50 mM of glutamate or NMA were used repeatedly,
to not interfere with endopeptidase involvement.
The samples were frozen until the GnRH radioimmunoassay was per-
formed. GnRH was measured in the collected fractions with a highly sen-
sitive RIA [17, 18]. GnRH was measured in duplicate. The intra- and
interassay coefficients were 14% and 18%, respectively [17, 18]. The val-
ues below the limit of detection (5 pg/7.5 min) were assigned that value.
The highly specific GnRH antiserum [19] was generously provided by Dr.
Y.F. Chen and V.D. Ramirez (Urbana, IL).
Study Protocols
Glutamate-receptor subtypes and GnRH inhibitory autofeedback. The
secretion of GnRH was studied with explants obtained on Fetal Days 20–
21 in the absence of any secretagogue (n 5 10 explants) or during repeated
exposures to 50 mM of NMA (N-methyl-D,L-aspartate; Sigma, Belgium)
(n 5 5 explants) or glutamate (Sigma) (n 5 5 explants). This particular
concentration of glutamate and NMDA was used to be comparable with
our previous conditions [7–9]. In a second experiment, explants obtained
on Fetal Days 20–21 and on Postnatal Days 5 and 15 were used to study
the relative contribution of NMDA and non-NMDA receptors at these
ages. For this purpose, each explant (n 5 5 for each age) was initially
exposed to 50 mM of glutamate alone and subsequently to 50 mM of
glutamate together with either 1 mM of D-2-amino-5-phosphopentanoic
acid (AP-5; Sigma) or 1 mM of 6,7-dinitroquinoxaline-2,3-dione (DNQX;
Tocris) to antagonize the NMDA or AMPA/kainate receptors, respectively,
or both antagonists together. Glutamate was used for 7.5 min at regular
intervals of 37.5 min (five fractions). The inhibitors were used for two
fractions of 7.5 min, immediately before and during incubation with glu-
tamate.
Glutamate biosynthesis from glutamine. With explants obtained on Fe-
tal Days 20–21 and on Postnatal Days 5 and 15, the secretion of GnRH
was evoked repeatedly every 37.5 min by incubation for 7.5 min with 20
mM of glutamate (n 5 5 for each age) or glutamine (n 5 5 for each age)
(glutamate and glutamine obtained from Sigma). It was been shown earlier
that this submaximal concentration allowed demonstration of a develop-
mental difference (15 versus 50 days), whereas such a difference was no
longer observed using 50 mM of the two amino acids [16]. At each age
studied, the involvement of glutaminase in GnRH secretion evoked by
glutamine was studied by coincubation with 10 mM of diazo-oxo-norleu-
cine (DON; Sigma), a glutaminase inhibitor. The inhibitor was used for 2
fractions of 7.5 min, immediately before and during incubation with glu-
tamine (20 mM). To establish that the glutaminase inhibitor was without
effect on glutamate stimulated GnRH release, the glutamate-evoked GnRH
secretion was studied in presence of 10 mM of DON as well.
GABAergic inputs. With explants obtained on Fetal Days 20–21 and
Postnatal Days 5 and 15, pulsatile GnRH secretion was studied without
(control) or with 100 mM of SR 95 531, a specific GABAA receptor an-
tagonist (generously provided by Sanofi-Winthrop, Brussels, Belgium) or
with 100 mM of muscimol (Sigma), a specific GABAA agonist, which
were both used throughout the entire experiment. For each age, 5 hypo-
thalamic explants were studied in each condition.
Parturition, oxytocin, and PGE2. Pulsatile GnRH secretion was studied
with hypothalamic explants obtained within 1–2 h after birth by cesarean
section performed immediately after the onset of labor (n 5 12) or after
natural parturition (n 5 12).
Hypothalamic explants obtained in fetuses (20–21 days of gestation)
were incubated with oxytocin (10 nM, Sigma), PGE2 (1 mM, Sigma) or
both used for the whole experiment. Five hypothalamic explants were
studied in each condition. Explants obtained on Postnatal Days 1, 5, and
15 were incubated without or in the presence of oxytocin (10 nM) or an
oxytocin antagonist (des-Gly-NH2d(CH2) 2[D-Tyr2,Thr4]OVT, 100 nM),
generously provided by Dr. Manning (Toledo, OH). Explants obtained on
Days 1 and 15 were incubated without or in the presence of PGE2
(1 mM), which was used for the whole experiment. For each age, 5 hy-
pothalamic explants were studied in each condition.
Statistical Analysis
The occurrence of significant pulses of GnRH secretion was deter-
mined with the Pulsar program, as described previously [20]. The individ-
ual interpulse interval and pulse amplitude as well as the mean 6 SD were
calculated. In some instances, such as with the oxytocin antagonist with
explants obtained on Postnatal Day 1, all the interpulse intervals were
equal, thus accounting for the SD being equal to zero. With explants ob-
tained in fetuses and neonatal rats on Postnatal Day 1, a GnRH interpulse
interval could not be calculated because only one secretory pulse in a
period of 4 h could be observed in some experiments. Therefore, pulsatile
GnRH secretion was estimated through the number of pulses observed in
a period of 4 h. The secretory response of GnRH evoked by the glutamate
receptor agonists was calculated as the difference between GnRH secreted
during incubation with the agonist and in the fraction collected immedi-
ately before. The effect of the different factors on GnRH pulse amplitude
and frequency was analyzed by one-way ANOVA followed by Student-
Newman-Keuls test. The threshold for significant difference was P , 0.05
RESULTS
Glutamate-Receptor Subtypes and Inhibitory
Autofeedback
With fetal hypothalamic explants, GnRH secretion was
usually found at or close to the detection limit and no pulses
were observed (Fig. 1A). In similar conditions, GnRH se-
cretion could be evoked by 50 mM of NMA or glutamate
(Fig. 1, B and C). Repeated stimulation with NMA every
37.5 min resulted in a progressive reduction and finally
disappearance of the GnRH secretory response (Fig. 1B),
indicating that the inhibitory autofeedback mediated
through NMDA receptors was already operative. However,
with 50 mM of glutamate as secretagogue, the response
showed no significant reduction (Fig. 1C), suggesting the
capacity of non-NMDA receptors to mediate sustained glu-
tamate-evoked secretion of GnRH at that time.
With hypothalamic explants obtained in fetal and 5- and
15-day-old rats, the GnRH release evoked by 50 mM of
glutamate was significantly decreased by coincubation with
AP-5 or DNQX used to antagonize the NMDA and AMPA/
kainate receptors, respectively (Table 1). While the inhibi-
tion obtained with AP-5 was similar at the three ages stud-
ied, DNQX accounted for a greater inhibition in the fetal
hypothalamus than postnatally, further suggesting the par-
ticular contribution of non-NMDA receptors in late fetal
life.
Glutamate Biosynthesis and GnRH Secretion
With hypothalamic explants obtained at 20–21 days of
gestation as well as 5 and 15 days postnatally, repeated
incubation with glutamate every 37.5 min could evoke a
GnRH secretory response. This response was maintained
with time at the three ages studied (Fig. 2). With explants
from fetal rats and 5-day-old rats, glutamine could evoke
some GnRH secretory response, which was, however, lower
than the response evoked by glutamate and disappeared
with repetition of the stimulatory episodes (Fig. 2, A and
B). Overall, the glutamine-evoked GnRH release repre-
sented 9% and 20% of the glutamate-evoked release in late
fetal life and at 5 days, respectively. At 15 days, glutamine
was as effective as glutamate in releasing GnRH and the
glutamine-evoked GnRH secretion did not show any de-
crease with time (Fig. 2C).
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FIG. 1. Representative profiles of GnRH secretion from fetal hypotha-
lamic explants incubated without any secretagogue or with NMA or glu-
tamate used repeatedly in the absence of bacitracin. The mean (6SD)
secretory response of GnRH to NMA and glutamate is given for each
stimulating episode. The asterisks denote significant differences versus the
initial response (P , 0.05).
TABLE 1. Effect of AP-5 and DNQX on GnRH release induced by glu-
tamate from hypothalamic explants obtained in rats aged 20–21 days of

































a Data are expresed in percentage of the response evoked by 50 mM of
glutamate. Using glutamate (Glu), the data are also provided as pg/7.5
min (mean 6 SD).
FIG. 2. The GnRH secretory response from hypothalamic explants ob-
tained in late fetal life and at 5 and 15 days postnatally was studied
repeatedly (every 37.5 min) using 20 mM of glutamate (Glu) or glutamine
(Gln) as secretagogues in the absence of bacitracin. The data are the mean
(6SD) secretory response of GnRH to glutamate or glutamine for each
stimulating episode.
Using 1025 M of DON, a glutaminase inhibitor, the
GnRH secretory response evoked by glutamine was nearly
abolished at 5 days (0.4 6 0.9 versus 1.7 6 1.7 pg/7.5 min)
and 15 days (0.8 6 1.8 versus 9.4 6 2.4 pg/7.5 min), in-
dicating that glutamine effects were likely to result from
transformation into glutamate by glutaminase. DON had no
effects on glutamate-evoked secretion at any of the ages
studied.
GABAergic Inputs
SR 95 531, a specific GABAA receptor antagonist, did
not induce any pulsatile GnRH secretion when fetal ex-
plants were studied (Fig. 3). On Postnatal Days 5 and 15,
the GnRH interpulse interval was significantly reduced by
the antagonist (74.4 6 2.1 versus 89.1 6 2.7, and 48.7 6
3.9 versus 60.9 6 2.6 min, respectively, SR 95 531 versus
control; Fig. 3), indicating early postnatal GABAergic in-
hibition of pulsatile GnRH secretion. Incubation of explants
with 100 mM of muscimol, a GABAA receptor agonist, did
not account for any pulsatile GnRH secretion in late fetal
life nor changes in GnRH pulse frequency at 5 and 15 days
(88.1 6 3.5 versus 89.1 6 2.7 min, and 59.4 6 2.2 versus
60.9 6 2.6 min, respectively, muscimol versus controls;
Fig. 3).
Effects of Parturition, Oxytocin, and PGE2
With explants obtained in neonatal rats born by cesarean
section performed after the onset of labor, no spontaneous
GnRH pulses could be observed (Fig. 4B) such as with
explants obtained in fetal rats before labor (Fig. 4A). With
explants obtained 2 h after completed parturition and vag-
inal delivery, spontaneous GnRH secretory pulses were
consistently observed (2.1 pulses/4 h) with a mean inter-
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FIG. 3. The mean (6SD) GnRH interpulse interval was studied with hy-
pothalamic explants obtained in late fetal life and at 5 and 15 days post-
natally in three conditions: control or incubation with SR 95531 or with
muscimol. The data are mean (6SD). The asterisks denote significant dif-
ferences versus data obtained in control conditions (P , 0.05).
FIG. 5. The mean 6 SD GnRH interpulse interval was studied with hy-
pothalamic explants from male rats aged 1, 5, and 15 days in three con-
ditions: control or incubation with oxytocin or with an oxytocin antago-
nist. Hypothalamic explants from male rats aged 1 and 15 days were also
studied in the presence of PGE2. The data are mean (6SD). The asterisks
denote significant differences versus data obtained in control conditions
(P , 0.05).
FIG. 4. Representative secretory profiles
of GnRH secretion from hypothalamic ex-
plants in six different conditions: (A) fetal
rats, 20–21 days of gestation; (B) rats born
by cesarean section performed after the
onset of labor; (C) neonatal rats 2 h after
natural parturition; (d) explants from fetal
rats at 20–21 days of gestation incubated
with oxytocin; (E) explants from fetal rats
at 20–21 days of gestation incubated with
PGE2; (F) explants from fetal rats at 20–21
days of gestation incubated with oxytocin
and PGE2.
pulse interval of 88.0 6 5.3 min when several pulses were
observed using a single explant (Fig. 4C). With explants
obtained in late fetal life (20–21 days of gestation), incu-
bation with oxytocin (10 nM) resulted in about one GnRH
secretory pulse in a period of 4 h (Fig. 4D). Using 1 mM
of PGE2, a similar effect was observed (Fig. 4E). With fetal
explants incubated with oxytocin and PGE2 both together,
two pulses were seen on average in a period of 4 h (Fig.
4F), such as with explants obtained in neonatal rats after
natural parturition and incubated in control conditions. Us-
ing explants obtained in male rats on Postnatal Day 1 (Fig.
5), the mean GnRH interpulse interval (92.5 6 3.9 min)
was significantly reduced by oxytocin (81.6 6 2.7 min) and
significantly increased by incubation with an oxytocin an-
tagonist (97.5 6 0.0 min). A facilitatory oxytocin effect on
GnRH pulse frequency remained at 5 and 15 days postna-
tally (81.6 6 2.7 versus 90.0 6 0.0 min, and 53.1 6 2.2
versus 60.8 6 2.5 min, respectively). The oxytocin antag-
onist resulted in a significant increase of the GnRH inter-
pulse interval at 15 days (68.3 6 2.5 min), while this effect
was not significant at 5 days (92.1 6 3.7 min). The antag-
onist effect suggested a facilitatory effect of endogenous
oxytocin on pulsatile GnRH secretion, which was effective
perinatally and persisted in postnatal life. As shown in Fig-
ure 5, PGE2 resulted in a significant decrease in GnRH
interpulse interval on Day 1 (89.1 6 2.7 versus 92.5 6
30.9) and 15 (53.8 6 2.9 versus 60.0 6 0.0 min).
DISCUSSION
In this paper, the neonatal occurrence of pulsatile GnRH
secretion in vitro has appeared to involve mechanisms dif-
ferent from those accounting for the postnatal increase in
frequency of pulsatile GnRH secretion before puberty. In
the latter period, reduced inhibitory GABAergic inputs and
increased glutamatergic stimulation through NMDA recep-
tors play key roles [13, 16], whereas such mechanisms are
not involved neonatally. At this early time, critical factors
were found to include glutamate biosynthesis and action
through non-NMDA receptors as well as oxytocin and
PGE2 that were studied in relation to parturition.
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When fetal rat hypothalamic explants were studied in
vitro, the GnRH pulse generator appeared to be silent or
below the threshold of detectable activity, whereas it was
operating from the day of birth onward. This raised the
question as to whether the apparent absence of pulses was
linked to true inactivity of the pulse generator or undetect-
able activity depending on amplitude limitation. It is pos-
sible that an ultrasensitive assay could detect some pulses
below the threshold of detection in our conditions, sup-
porting an amplitude-modulated process. We did, however,
not observe any difference in pulse amplitude, whereas am-
plitude was found to increase in similar conditions with
explants obtained in female rats in the afternoon of proes-
trus [21]. In addition, obvious changes in pulse amplitude
were seen when GnRH secretion was evoked using differ-
ent secretagogues but not in the absence of such agents.
We have shown that intermittent incubation with gluta-
mate every 37.5 min can cause GnRH release and mimic
the spontaneous secretion seen with explants obtained in
adult rats. These data indicate that the apparent silence of
the GnRH pulse generator in the fetal hypothalamus does
not result from immature synthesis of GnRH or absence of
glutamate receptors. Indirectly, because the secretory re-
sponse of GnRH is kept unchanged during 4 h, neuronal
damage through NMDA-receptor-mediated excitotoxic ef-
fects is unlikely to occur in our conditions. The GnRH in-
hibitory autofeedback already operates in the fetal hypo-
thalamus and needs to be prevented by the prolyl endopep-
tidase inhibitor bacitracin to observe intermittent NMDA-
evoked GnRH response from fetal hypothalamic explants
[7]. This autofeedback can be the reason why repeated
NMDA stimulations resulted in progressive disappearance
of the GnRH secretory response. Because the glutamate-
evoked release of GnRH could be obtained repeatedly and
did not decrease in the absence of bacitracin, it could be
suggested that non-NMDA receptors, which do not seem
to be involved in any inhibitory autofeedback [10], play an
important role perinatally. In such conditions, endopepti-
dase degradation does not appear to be a key factor that
restrains the fetal pulse generator because prolyl endopep-
tidase inhibition does not result in occurrence of pulsatile
secretion [7].
Our data indicate that both NMDA and non-NMDA re-
ceptors are present and functional in the fetal hypothala-
mus. Developmental changes in NMDA receptors were ob-
served in several extrahypothalamic regions such as cortex,
hippocampus, and cerebellum [22–24]. In the preoptic area,
the ratio of NR1 and NR2a and 2b subunits was reported
to change as well [25] and could explain variation in sen-
sitivity to NMDA receptor activation. The most dramatic
increase in expression of NR1, a subunit that is necessary
for a functional NMDA receptor, seemed to take place be-
tween Fetal Day 18 and Postnatal Day 10. In the rat gray
matter, genes encoding for the kainate receptor subunits
were expressed from Fetal Day 14 [26]. Their expression
went through a peak in the late fetal/early postnatal period,
when the contribution of non-NMDA receptors seems to be
predominant in our model. The mRNA editing of different
subunits of the non-NMDA receptors, which determines
their gating characteristics, is developmentally regulated
[27] and may also contribute to the ontogenic changes in
glutamate sensitivity.
A major pathway for glutamate biosynthesis is from glu-
tamine under the action of glutaminase [28]. The mecha-
nism of glutamate recycling in the brain involves reuptake
by astroglial cells of the glutamate released at the synapse
level and transformation into glutamine, which is delivered
to glutamatergic neurons where glutaminase causes trans-
formation into glutamate. With DON, a glutaminase inhib-
itor, we confirmed glutaminase involvement in glutamine
effect on GnRH release perinatally and postnatally, in
agreement with data reported previously later in life [16].
In such conditions, the glutamine evoked secretion of
GnRH compared with that evoked by glutamate provides
an indirect assessment of glutamate biosynthesis from glu-
tamine. Our data suggest that a critical increase in gluta-
mate biosynthesis may occur during the early postnatal pe-
riod. This is in line with our previous observations that
inhibition of glutamine-evoked GnRH secretion required
higher DON concentrations at 50 days than at 15 days,
suggesting an increase in glutaminase activity throughout
development [16]. Roth et al. [29], however, did not find
any ontogenic change in glutaminase mRNA in the me-
diobasal hypothalamus and the preoptic area. One limit in
the significance of such studies is the regional specificity
of changes in the face of the ubiquity of the enzyme. Then,
if low glutamate biosynthesis from glutamine partly ac-
counts for absent pulsatile secretion in late fetal life, it is
noteworthy that the mechanism could be rather specific of
the neuronal-glial apparatus controlling GnRH secretion, as
opposed to the involvement of non-NMDA receptors,
which appeared to be a general feature of the central ner-
vous system at that particular period.
The involvement of GABA receptors in the control of
GnRH secretion is largely supported by in vitro and in vivo
studies. In the monkey, tonic inhibition by GABA neurons
before onset of puberty was evidenced by push-pull per-
fusion and infusion in the vicinity of the median eminence
of the antagonist bicucullin [11, 30] or an antisense oligo-
deoxynucleotide for glutamic acid decarboxylase [12, 31].
Using bicucullin or antisense strategies, we observed a
GABAergic inhibition of pulsatile GnRH secretion from
hypothalamic explants of male rats at 15 days that had dis-
appeared by 25 days [13]. The present data confirm those
observations and extend them to the early postnatal period
because the GABAA receptor antagonist SR 95 531 led to
an acceleration of GnRH pulse frequency at 5 and 15 days
of age. However, incubation with SR 95 531 did not induce
any pulsatile GnRH secretion from fetal explants, suggest-
ing that GABAergic inhibition did not account for the pre-
natal absence of pulsatile GnRH secretion. Such a finding
raised the question as to whether the role of GABA could
be facilitatory instead of inhibitory at that time. A stimu-
latory effect of GABA was found in the embryonic hypo-
thalamus [14] as well as in immortalized cell lines retaining
the capacity of pulsatile GnRH secretion [15], suggesting
that GABAA receptors could mediate a stimulatory effect
on GnRH secretion in the fetal hypothalamus. In the present
study, with fetal hypothalamic explants by the end of ges-
tation, the GABAA receptor agonist muscimol was unable
to elicit pulsatile GnRH secretion or to increase the gluta-
mate-evoked GnRH release. From this, however, we cannot
conclude that GABA is not involved as a direct stimulator
of GnRH neurons because such an effect could coexist with
inhibitory effects on an extrinsic GnRH pulse generator and
thus not appear in our conditions. The opposing GABA
effects during development can involve differences in re-
ceptor subtype, changes in the subunit composition of
GABAA receptors, [32], in chloride homeostasis [33], and
in the relative importance of glutamate input compared with
GABA [34]. The changes in GABA effect may also depend
on alterations in the population and sensitivity of interneu-
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rons because GABA could act through interneurons [35,
36].
The neonatal occurrence of pulsatile GnRH secretion
due to a withdrawal from inhibitory placental factors ap-
peared to be unlikely because occurrence of GnRH pulses
should then be expected to occur after both cesarean section
and natural parturition, while they were observed in the
latter condition only. Thus, we hypothesized a facilitatory
role of endocrine events related to parturition being ob-
servable only after completion of this process. Oxytocin
could be involved because the peptide is synthesized at the
uterine as well as hypothalamic level. Oxytocin neurons are
located in the paraventricular and supraoptic nuclei, their
axons terminating in different areas, including the median
eminence and the rostral hypothalamus [37]. In the female,
oxytocin is known to play an important role in parturition
and lactation [38] and also appears to act centrally to influ-
ence maternal and mating behavior [39–41]. Moreover,
oxytocin has been shown to stimulate GnRH release from
medial basal hypothalamic explants in male rats [42] and
to stimulate GnRH secretion on the afternoon of proestrus
in the cycling female rat [43]. These effects were observed
at low concentrations, consistent with physiologic levels. In
the present study, we showed that oxytocin could cause
pulsatile GnRH secretion to occur from explants obtained
in late fetal life, suggesting a role for this factor in the
initiation of pulsatile GnRH secretion neonatally. If oxy-
tocin accounts for such an effect in vivo, the contribution
of peptide of maternal versus fetal and peripheral versus
central origin remains to be elucidated. Some studies have
described an increase in fetal oxytocin during the end of
gestation [44], while increased oxytocin of maternal origin
during parturition could also be involved in the mechanism.
However, some studies provided contradictory data con-
cerning a possible placental transfer of oxytocin [45–47].
With the use of hypothalamic explants of neonatal rats on
Day 1, we showed that facilitatory oxytocin effects on
GnRH secretion were not limited to late fetal life. More-
over, an oxytocin antagonist was able to decrease pulsatile
GnRH secretion by increasing the GnRH interpulse inter-
val, and this effect on GnRH remained in postnatal life at
15 days. These data suggested a possible life-long effect of
endogenous oxytocin independent of parturition and thus is
likely to originate in the hypothalamus and to involve en-
dogenous peptide because the antagonist is effective in the
absence of oxytocin added in the incubation medium. In-
terestingly, the oxytocin antagonist did not account for any
significant effect using explants obtained at 5 days of age.
This might suggest that there is an early postnatal matura-
tion process of endogenous oxytocin input to GnRH neu-
rons that is not yet fully completed by the age of 5 days.
Indeed, some studies have shown that significant amounts
of mature oxytocin are detected in the brain only from the
second week of life [48, 49]. Very recently, a reduction of
LH secretion was reported following administration of an
oxytocin antagonist in adult women, thus indicating that
our in vitro data obtained in the rat could be relevant to
human physiology or pathophysiology [50]. PGE2, which
is also synthesized at the central as well as the uterine level,
has been described as a potent stimulator of GnRH release
[51]. Many studies suggest a role for PGE2 in the median
eminence, where it is secreted by astrocytes in response to
growth factors such as TGF-alpha [52]. Though we did not
exclude that oxytocin concentration or duration of exposure
may affect GnRH pulse frequency, the combined effects of
PGE2 and oxytocin suggest that achievement of physiolog-
ical GnRH pulse frequency requires different neuromodu-
lators. Such a concept is consistent with redundancy of
pathways, which characterizes most biological systems in-
volved in homeostasis of important functions in the hypo-
thalamus.
In conclusion, pulsatile GnRH secretion occurs soon af-
ter birth in the rat hypothalamus in vitro. There is no evi-
dence of disappearing inhibitors, while our data suggest the
involvement of several facilitatory factors, namely oxyto-
cin, PGE2, and glutamate synthesis from glutamine. A stim-
ulatory oxytocin effect on GnRH secretion persists later in
postnatal life and its physiological or pathophysiological
significance is still to be elucidated.
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